Term ends Oct 24, 2036 · Medium confidence
20-year base term ends Oct 24, 2036
Why Medium: A parent in the chain could not be resolved.
Held by B3AR Therapeutics, Inc.
Filed Jun 26, 2018 as application 16/018,945 · Granted Mar 5, 2019
Base term, 20 years from filing
Today
2016
2036
Clock starts
Oct 24, 2016
Oct 24, 2016
Term ends
Oct 24, 2036
Oct 24, 2036
Granted
Mar 5, 2019
Mar 5, 2019
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 24, 2016, when application 15/332,956, the earliest non-provisional in its chain, was filed (this one was filed Jun 26, 2018); a parent in its chain could not be resolved (the next row) | Oct 24, 2036 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 24, 2036 | Medium confidence |
This family
| US 10,065,922 | Lapsed on the fee record Sep 2026 | Sep 2026 |
| US 10,221,126 | this patent Oct 2036 | Oct 2036 |
| US 10,844,004 | In force Oct 2036 | Oct 2036 |
| US 11,691,944 | In force Oct 2036 | Oct 2036 |
| US 12,435,026 | In force Oct 2036 | Oct 2036 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 16, 2018 Reel 46361, frame 263 | Zhao, Dalian; J-Star Researcj. Inc. | Velicept Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 16, 2018 Reel 46361, frame 351 | Mobele, Bingidimi Itute; Rondaxe Pharma, LLC | Velicept Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 16, 2018 Reel 46361, frame 375 | Stevens, Raymond E. | Velicept Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 7, 2019 Reel 50642, frame 74 | Velicept Therapeutics, Inc. | Oxford Finance LLC, as Collateral Agent | Security Interest |
| May 19, 2021 Reel 56285, frame 273 | Velicept (Assignment for the Benefit of Creditors), LLC; Velicept Therapeutics, Inc. | B3AR Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2036
Term ends Oct 24, 2036.
Citations
4
later US patents cite this one
That is above the median of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.